Stockscreener 앱 받기
8.59
4.25%
0.35
시장 영업 전:
8.59
전일 마감가:
$8.24
열려 있는:
$8.29
하루 거래량:
261.72K
Relative Volume:
0.83
시가총액:
$307.95M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+11.27%
1개월 성능:
+60.26%
6개월 성능:
+109.00%
1년 성능:
-53.32%
1일 변동 폭
$8.285
$8.98
1주일 범위
$7.60
$8.98
52주 변동 폭
$2.88
$20.37
Bioage Labs Inc Stock (BIOA) Company Profile
명칭
Bioage Labs Inc
전화
510-806-1445
주소
5885 HOLLIS STREET, EMERYVILLE
BIOA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIOA
Bioage Labs Inc
|
8.59 | 295.45M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
115.89 | 51.60B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.60 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.28 | 28.04B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.72 | 20.52B | 3.08B | 1.24B | 1.07B | 25.61 |
Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-02-28 | 개시 | William Blair | Mkt Perform |
| 2024-12-10 | 다운그레이드 | Morgan Stanley | Overweight → Underweight |
| 2024-12-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-12-09 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-10-21 | 개시 | Citigroup | Buy |
| 2024-10-21 | 개시 | Jefferies | Buy |
| 2024-10-21 | 개시 | Morgan Stanley | Overweight |
모두보기
Bioage Labs Inc 주식(BIOA)의 최신 뉴스
Is BioAge Labs Inc. (Y7G) stock a buy on weakness2025 Short Interest & Risk Adjusted Buy and Sell Alerts - newser.com
How interest rate cuts could boost BioAge Labs Inc. stock2025 Earnings Impact & Accurate Intraday Trading Signals - newser.com
Is BioAge Labs Inc. stock recession proofWeekly Stock Report & Weekly Breakout Opportunity Watchlist - newser.com
Is BioAge Labs Inc. stock a buy before product launchesMarket Volume Report & Weekly Top Stock Performers List - newser.com
Is BioAge Labs Inc. (Y7G) stock supported by free cash flowJuly 2025 Setups & AI Powered Market Entry Ideas - newser.com
How to use Fibonacci retracement on BioAge Labs Inc.Gap Up & Verified Stock Trade Ideas - newser.com
Order flow analysis tools used on BioAge Labs Inc.Entry Point & Low Risk Entry Point Tips - newser.com
Will BioAge Labs Inc. (Y7G) stock sustain uptrend momentumTrade Analysis Report & Daily Risk Controlled Trade Plans - newser.com
How BioAge Labs Inc. (Y7G) stock stacks up against competitorsQuarterly Portfolio Report & Safe Capital Growth Tips - newser.com
Will BioAge Labs Inc. (Y7G) stock hit analyst forecastsQuarterly Portfolio Review & Advanced Swing Trade Entry Plans - newser.com
How supply shortages influence BioAge Labs Inc. (Y7G) stockJuly 2025 Macro Moves & Capital Efficiency Focused Ideas - newser.com
Top 3 Biotech Stocks Capitalizing on the AI Revolution - Investing.com India
BIOA: NLRP3 inhibitor targets cardiovascular risk in obesity; APJ agonist INDs planned next year - TradingView
BioAge Labs (BIOA) Price Target Increased by 20.83% to 9.86 - Nasdaq
BioAge Labs Inc. stock trendline breakdownGold Moves & Fast Entry Momentum Trade Alerts - newser.com
Can BioAge Labs Inc. stock resist sector downturnsWeekly Profit Analysis & Free Weekly Chart Analysis and Trade Guides - newser.com
Published on: 2025-11-15 16:22:46 - newser.com
Bioage Labs Inc (BIOA) 재무 분석
Bioage Labs Inc (BIOA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
6.17%
0.67%
자본화:
|
볼륨(24시간):